UT Southwestern and Komen Foundation Offer Breast Care Fellowship

Publication
Article
OncologyONCOLOGY Vol 12 No 8
Volume 12
Issue 8

The Center for Breast Care at UT Southwestern Medical Center in Dallas and the Susan G. Komen Breast Cancer Foundation have teamed up to offer a new 1-year fellowship for physicians interested in the multidisciplinary care of breast

The Center for Breast Care at UT Southwestern Medical Center in Dallas and the Susan G. Komen Breast Cancer Foundation have teamed up to offer a new 1-year fellowship for physicians interested in the multidisciplinary care of breast cancer patients.

This program was designed to provide the physician with an in-depth understanding of the entire scope of a breast-cancer patient’s treatment. It places special emphasis on refining physicians’ skills in counseling and discussing such topics as quality-of-life and end-of-life issues.

Treating the Whole Patient

"We are delighted to join the Komen Foundation and offer a fellowship that specifically addresses the needs of physicians in treating breast cancer patients comprehensively," said Dr. George Peters, executive director of the Center for Breast Care and holder of the

Marilyn R. Corrigan Distinguished Chair in Breast Cancer Surgery. "This fellowship has the potential to set a new standard for multidisciplinary breast care," said Elda Railey, director of national grants. "Through this program, the fellows will broaden their understanding of all the treatment issues faced by breast cancer patients. The program also provides education in genetics and the disease’s effects on a patient’s daily life and family. It is a comprehensive approach to training in today’s world of specialization."

Fellows will be instructed in pathology, plastic surgery, and medical oncology, radiation oncology, radiology, surgery, genetics, and psychiatry/psychology at UT Southwestern. They will also spend 1 day a month at the Komen Foundation headquarters developing their communication skills. Successful candidates must hold an md or equivalent degree and be board-eligible or board-certified in one of the above areas.

Recent Videos
The use of chemotherapy trended towards improved recurrence-free intervals in older patients with high-risk tumors as determined via the MammaPrint assay.
Use of a pharmacist-directed resource appears to improve provider confidence and adverse effect monitoring for patients undergoing infusion therapy.
Reshma L. Mahtani, DO, describes how updates from the DESTINY-Breast09, ASCENT-04, and VERITAC-2 trials may shift practices in the breast cancer field.
Multidisciplinary care can help ensure that treatment planning does not deviate from established guidelines for inflammatory breast cancer management.
Photographic and written documentation can help providers recognize inflammatory breast cancer symptoms across diverse populations.
The use of guideline-concordant care in breast cancer appears to be more common in White populations than Black populations.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Related Content